BackgroundPrevalence of inflammatory bowel disease (IBD) exceeds 0.3% in N. America, Europe, and Oceania, but many Westernized nations report decreasing hospitalization rates (HR) following the advent of biologics. However, IBD incidence is rapidly rising in newly industrialized countries in Asia and S. America, which may correspond to increasing HRs in those regions.
展开▼